Study on the factors inducing hypersensitivity of the blood vessels to pressor substances in toxemia of pregnancy
妊娠毒血症血管对升压物质过敏的影响因素研究
基本信息
- 批准号:60570769
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1985
- 资助国家:日本
- 起止时间:1985 至 1986
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Attention has recently been focused on hypersensitivity of the blood vessels to pressor substances as pathogenesis of toxemia of pregnancy. Natriuretic factor is reported to be involved in regulation of Na retention which is suggested to be one of the causative factors leading to essential hypertension. Natriuretic factor has the stimulatory effect on Na secretion from the kidney by inhibition of <Na^+> - <K^+> ATPase, through which, on the other hand, the increased intracellular Na retention may be brought about in the arterial wall. Consequently, increased intracellular Ca resulting from <Na^+> - <Ca^(++)> exchange reaction may induce hypersensitivity of the blood vessels to pressor substances. Secretion of natriuretic factor may be stimulated during pregnancy through increased body fluid and Na retention, which might result in toxemia of preganacy. Measurement of the activity of <Na^+> - <K^+> ATPase inhibitor in the blood by Hamlyn's method revealed that its activity in toxemia of pregnancy was significantly higher than in normal pregnancy and significant correlation was observed between mean blood pressure and its activity. Higher activity in the umbilical vein than in the umbilical artery indicated production of the factor in the placenta.Prostaglandin(PG) <I_2> has the lowering effect on blood pressure by relaxation of the blood vessels. Impaired activity.of PG <I_2> production in the endothelium of the blood vessels, therefore, may increase sensitivity of the vessels to pressor substances. Our experimental results showed that production of PG <I_2> was activated in mild toxemia more than in normal pregnancy, whereas in severe one its production was restricted to great extent so that toxemia may be aggravated.
妊娠毒血症的发病机制主要是血管对加压物质的超敏反应。据报道,利钠因子参与钠潴留的调节,这被认为是导致原发性高血压的原因之一。利钠因子通过抑制<Na^+> - <K^+> atp酶刺激肾内Na分泌,另一方面可能导致动脉壁内细胞内Na潴留增加。因此,<Na^+> - <Ca^(++)>交换反应引起的细胞内Ca升高可能引起血管对加压物质的超敏反应。在妊娠期,尿钠因子的分泌可能通过增加体液和钠潴留而受到刺激,从而导致妊娠毒血症。Hamlyn's法测定<Na^+> - <K^+> atp酶抑制剂在妊娠毒血症中的活性明显高于正常妊娠,其活性与平均血压有显著相关性。脐静脉比脐动脉活性高表明胎盘中产生了该因子。前列腺素(PG) <I_2>通过血管舒张而降低血压。受损的活动。因此,血管内皮中PG <I_2>的产生可能增加血管对压力物质的敏感性。我们的实验结果表明,在轻度毒血症中,PG <I_2>的产生比正常妊娠更活跃,而在重度妊娠中,PG <I_2>的产生受到很大程度的限制,从而可能加重毒血症。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
佐藤和雄,関博之: ペリ.ネイタルケア. 5. 627-632 (1986)
Kazuo Sato,Hiroyuki Seki:围产期护理。5. 627-632 (1986)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Satoh and H.Seki: "Prostaglandins and toxemia of pregnancy" Perinatal Care (in Japanese). 5. 627-632 (1986)
K.Satoh 和 H.Seki:“前列腺素和妊娠毒血症”围产期护理(日语)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
佐藤和雄,関博之: 産婦人科の世界. 39. 135-138 (1987)
Kazuo Sato,Hiroyuki Seki:妇产科世界 39. 135-138 (1987)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
佐藤和雄,関博之: 周産期医学. 16. 989-995 (1986)
Kazuo Sato,Hiroyuki Seki:围产期医学。16. 989-995 (1986)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Satoh and H.Seki: "On dynamic aspect of PG prduction in toxemia of pregnancy" Sanfujinka no Sekai (in Japanese). 39. 135-138 (1987)
K.Satoh 和 H.Seki:“妊娠毒血症中 PG 产生的动态方面”Sanfujinka no Sekai(日语)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATOH Kazuo其他文献
SATOH Kazuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATOH Kazuo', 18)}}的其他基金
Development of rare metal free high performance flexible oxide transistors and logic circuits
开发无稀有金属高性能柔性氧化物晶体管和逻辑电路
- 批准号:
16K06288 - 财政年份:2016
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Basic Study for Tumor Vaccine Development in Human Endometrial Adenocarcinoma-development of tumor vaccination with plasmid DNA containing fusion gene encoding c-erbB2 protein
人子宫内膜腺癌肿瘤疫苗研制的基础研究——含c-erbB2蛋白融合基因的质粒DNA肿瘤疫苗的研制
- 批准号:
10470349 - 财政年份:1998
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
A molecular biological study of endometrial cancer metastasis
子宫内膜癌转移的分子生物学研究
- 批准号:
05454457 - 财政年份:1993
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Action mechanism of the regulatory factors in oocyte maturation and embryo growth
卵母细胞成熟及胚胎生长调控因子的作用机制
- 批准号:
62480350 - 财政年份:1987
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
血管内皮细胞CD36/Na-K ATPase信号通路在肥胖引起血管胰岛素抵抗和血管损伤中的作用和机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
六磷酸肌醇激酶-1(IP6K1)调控Na-K-ATPase alpha 1的分子机制及其在心肌肥厚中作用的研究
- 批准号:81870232
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
Na+-K+-ATPase特异性DR抗体对大鼠心肌缺血/再灌注损伤的保护及分子机制研究
- 批准号:81400232
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
MEK阻害剤関連網膜症の漿液性網膜剥離におけるNa/K ATPaseとAQPの病態意義解明
阐明 Na/K ATP 酶和 AQP 在 MEK 抑制剂相关性视网膜病引起的浆液性视网膜脱离中的病理学意义
- 批准号:
24K19802 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetes
健康和糖尿病中通过胰岛 Na /K -ATP 酶的促分泌素和 Gi/o-GPCR 信号传导
- 批准号:
10717045 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Na+/K+-ATPase and regulation of testis and sperm function
Na /K -ATP酶与睾丸和精子功能的调节
- 批准号:
RGPIN-2020-04585 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Discovery Grants Program - Individual
Cellular Pathophysiology of Neuronal Na/K-ATPase Dysfunction
神经元 Na/K-ATP 酶功能障碍的细胞病理生理学
- 批准号:
10539624 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Cellular Pathophysiology of Neuronal Na/K-ATPase Dysfunction
神经元 Na/K-ATP 酶功能障碍的细胞病理生理学
- 批准号:
10646335 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Determining the role of DNA methylation in the tissue-specific expression of the Na,K-ATPase-Na/H exchanger pH regulatory system genes.
确定 DNA 甲基化在 Na,K-ATPase-Na/H 交换 pH 调节系统基因的组织特异性表达中的作用。
- 批准号:
10202996 - 财政年份:2021
- 资助金额:
$ 1.34万 - 项目类别:
Na+,K+-ATPaseによるK+選択的結合機構の構造生物学的研究
Na+,K+-ATPase K+选择性结合机制的结构生物学研究
- 批准号:
21K06109 - 财政年份:2021
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Na+/K+-ATPase and regulation of testis and sperm function
Na /K -ATP酶与睾丸和精子功能的调节
- 批准号:
RGPIN-2020-04585 - 财政年份:2021
- 资助金额:
$ 1.34万 - 项目类别:
Discovery Grants Program - Individual
Development of new Na,K-ATPase inhibitor and the study of its reaction mechanism
新型Na,K-ATP酶抑制剂的研制及其反应机理研究
- 批准号:
21K06611 - 财政年份:2021
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Na+/K+-ATPase and regulation of testis and sperm function
Na /K -ATP酶与睾丸和精子功能的调节
- 批准号:
RGPIN-2020-04585 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




